Financial News · Live Terminal

Page 1209 of 2933

Gateway Mining Intersects Gold Mineralization at Western Australia Project

Gateway Mining (ASX:GML) intersected gold mineralization at its Yandal project in Western Australia during initial first-pass air-core drilling across Celia South and the Great Western Shear Corridor structures, according to a Wednesday filing with the Australian bourse.Results include 12 meters at 1.4 grams per tonne grade of gold from 60 meters, 10 meters at 2.2 g/t grade of gold from 66 meters, and 16 meters at 1 g/t grade of gold from 104 meters, the filing said.Additionally, reverse circulation drilling will start in the week of June 15 to focus on depth extensions, per the filing.

ASX:GML

Asia48d ago

PMET Resources' Quebec Portfolio Surface Exploration Encounters Lithium-Caesium-Tantalum Pegmatite Discoveries

PMET Resources (ASX:PMT) encountered multiple new lithium-caesium-tantalum pegmatite discoveries at its broader portfolio of properties in Quebec, Pikwa, Pontois, Pontax, and particularly Shaakichiuwaanaan, according to a Wednesday Australian bourse filing.A high-grade caesium pegmatite discovery, Cosma, is located around 22 kilometers west of the CV5 pegmatite deposit at Shaakichiuwaanaan, with an outcrop grab assay of 9.4% grade of caesium oxide and 267 parts per million (ppm) grade of tantalum pentoxide, as well as a channel assay of 4.4 meters at nearly 4% grade of caesium oxide and 609 ppm grade of tantalum pentoxide.A spodumene pegmatite discovery, Felix, is located near Shaakichiuwaanaan, with outcrop assays including 1.8% grade of lithium oxide and 1.2% grade of lithium oxide. Another spodumene pegmatite discovery, Skald, is located at the Pontois property, with an outcrop assay of 2.9% grade of lithium oxide.A new caesium pegmatite discovery, Overload, is located at the Pontax property, with an outcrop assay of 7.5% grade of caesium oxide and 3,768 ppm grade of tantalum pentoxide, per the filing.

ASX:PMT

Asia48d ago

Victory Metals Signs Agreement With Wajarri Yamaji for Western Australia Mining Project

Victory Metals (ASX:VTM) has signed an agreement with the Wajarri Yamaji Aboriginal Corporation (WYAC) to support the granting of a mining license for its North Stanmore project in Western Australia, securing traditional owner consent and land access arrangements, according to a Wednesday Australian bourse filing.The company said the agreement is a key step in the native title process to help secure a mining license grant for North Stanmore, advancing the project alongside the advancing pre-feasibility study and the previously disclosed $190 million Export-Import Bank letter of intent.

ASX:VTM

Asia48d ago

Market Chatter: SK Hynix Eyes Doubling Memory Chip Output Over Five Years

SK Hynix (KRX:000660) aims to double the output of key AI memory chips over the next five years, projecting a global supply shortage that could last until 2030, Bloomberg News reported on Wednesday, citing chairman Chey Tae-won.Tae-won said in Taipei that the company is boosting investment to tackle the supply-demand gap, though exact figures are elusive due to fluctuating costs of land, equipment, and electricity, the news wire said.Chey said the company is committed to funding the expansion of chip wafer capacity at all necessary levels, the publication said.As a dominant player alongside Samsung Electronics (KRX:005930) and Micron, SK Hynix has benefited from the surge in data center construction, with recent multitrillion-dollar spending projections from tech giants helping push its valuation and Micron's past $1 trillion last week.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

KRX:000660KRX:005930

Asia48d ago

ASX Preview: Australian Shares Set to Rise as Oil Advances, Gold Falls on Strong US Labor Data; Northern Star Resources Increases Estimated Mineral Resources, Ore Reserves

Australian shares are poised to rise on Wednesday, tracking higher oil prices after crude climbed to a one-week high amid volatile trading as markets weighed uncertain Iran-US negotiations and ongoing tensions around the Strait of Hormuz.Market sentiment was also influenced by a softer gold price as stronger-than-expected US labor data reinforced expectations that the Federal Reserve will keep interest rates elevated for longer.Overnight, the S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average rose 0.1%, 0.03%, and 0.5%, respectively.In the macroeconomy, the Australian national accounts report is due at 11:30 am Sydney time.In corporate news, Northern Star Resources (ASX:NST) said its estimated mineral resources increased 26% to 88.9 million ounces as of March 31, while its estimated ore reserves jumped 27% to 28.4 million ounces.Ampol's (ASX:ALD) proposed acquisition of fuel and convenience retailer EG Australia received approval from the Australian Competition and Consumer Commission.Australia's benchmark index edged down 5 points to close at 8,724.40 on Tuesday.

ASX 200ASX:ALDASX:NST

Asia48d ago

Ampol Secures ACCC Nod for Proposed Acquisition of Fuel, Convenience Retailer

Ampol's (ASX:ALD) proposed acquisition of fuel and convenience retailer EG Australia received approval from the Australian Competition and Consumer Commission (ACCC), according to a Wednesday filing with the Australian bourse.The approval is conditional on the company giving an executed court-enforceable undertaking to the ACCC to divest 41 sites to Metro Petroleum and is subject to the expiry of the statutory 14-day review period, the filing said.The acquisition is expected to be completed on June 30, per the filing.

ASX:ALD

Asia48d ago

Cynata Therapeutics Gets Positive European Opinion for Acute Graft Versus Host Disease Trial

Cynata Therapeutics (ASX:CYP) received a positive opinion from the European Medicines Agency's Paediatric Committee for a plan to develop its CYP-001 product candidate for the treatment of acute graft versus host disease, according to a Wednesday filing with the Australian bourse.The committee has agreed to the company's proposed pediatric investigation plan, which is a requirement to start a phase 3 clinical trial in the European Union.CYP-001 is designed for intravenous use to modulate the immune system and improve response rates and survival outcomes in acute graft versus host disease, an often life-threatening complication of bone marrow transplantation and similar procedures, per the filing.Cynata Therapeutics plans to launch a phase 3 clinical trial first in adults, and once the primary analysis of the adult trial is complete, it plans to start a pediatric clinical trial.

ASX:CYP

Asia48d ago

Pacific Edge Completes Over NZ$36 Million Equity Raise; Shares Tumble 5%

Pacific Edge (NZE:PEB, ASX:PEB) completed its NZ$36.1 million equity raising at NZ$0.17 per share, comprising a NZ$25.4 million placement and an oversubscribed retail offer that drew NZ$46 million in applications, with NZ$10.7 million accepted, according to a Wednesday Australia and New Zealand bourse filing.The company raised NZ$10.2 million through a share purchase plan and a further NZ$500,000 under placement capacity from the retail proceeds, per the filing.The company will issue 62.7 million new shares under the retail offer, expected to be allotted and to commence trading on the New Zealand Exchange on Thursday, ranking equally with existing ordinary shares, the filing added.The company's Kiwi shares tumbled 5% in recent Wednesday trade.

ASX:PEBNZE:PEB

Asia48d ago

Ardea Resources Says Finalization of Definitive Feasibility Study to Extend Beyond June

Ardea Resources (ASX:ARL) said completion of the definitive feasibility study final report for the Kalgoorlie project-Goongarrie Hub in Western Australia is expected to extend beyond June 30, according to a Wednesday filing with the Australian bourse.Value engineering opportunities identified during the quarter may need further input for the study before finalization, the filing said.The company initiated a scoping study to assess the potential recovery of scandium and other critical minerals, which is anticipated to be completed in September, per the filing.

ASX:ARL

Asia48d ago

Opthea Poised to Resume Trading on Australian Securities Exchange After Decision to Advance Lung Disease Drug Candidate

Opthea (ASX:OPT) expects to resume trading on the Australian Securities Exchange on or around Wednesday following a decision to advance its OPT-302 drug candidate for the treatment of lymphangioleiomyomatosis, according to a same-day filing with the Australian bourse.Lymphangioleiomyomatosis is a chronic lung disease that mainly affects women, characterized by the destruction of lung tissue.Opthea believes its scientific assets, manufacturing capabilities, and intellectual property portfolio "provide a strong foundation" for a strategy focused on the disease, where a significant unmet medical need exists.The company has launched a staged development program over an expected 18-month period to evaluate OPT-302, it said.

ASX:OPT

Asia48d ago

Megaport Wins New AI Infrastructure Contracts Totaling Nearly AU$500 Million

Megaport (ASX:MP1) won four new artificial intelligence (AI) infrastructure contracts worth roughly AU$458.9 million in total, according to a Wednesday filing with the Australian bourse.The company also plans to establish an on-demand graphics processing units (GPU) pool, supported by an investment of AU$350 million, to grant enterprise customers access to AI infrastructure through contracted and consumption-based commercial models, the filing said.Additionally, the company launched a fully underwritten 1-for-3.08 pro rata accelerated non-renounceable entitlement offer to raise AU$827.3 million to secure the capital expenditure required to fulfill the new contracts and seed the GPU pool, per the filing.

ASX:MP1

Asia48d ago

Tivan Signs AU$10 Million Option Underwriting Agreement, Raises Further AU$5 Million Via Placement

Tivan (ASX:TVN) signed an underwriting agreement with Evolution Capital to underwrite the exercise of up to AU$10 million of its listed TVNO options, exercisable at AU$0.30 each and expiring on June 30, with Regal Partners agreeing to sub-underwrite AU$7.5 million of the underwritten amount, according to a Wednesday Australian bourse filing.The company said it has also signed a binding term sheet for a AU$5 million share placement with ETFS Capital at AU$0.30 per share, with placement shares subject to a standstill arrangement upon issue.The arrangements ensure Tivan will receive a minimum of AU$15 million through mid-year, enabling it to accelerate development planning and exploration at its key projects in Australia and Timor-Leste, the filing added.

ASX:TVN

Asia48d ago

Northern Star Resources Increases Estimated Mineral Resources, Ore Reserves

Northern Star Resources (ASX:NST) said its estimated mineral resources increased 26% to 88.9 million ounces as of March 31, while its estimated ore reserves jumped 27% to 28.4 million ounces, according to a Wednesday filing with the Australian bourse.The company is focused on its Kalgoorlie Consolidated Gold Mines operations in Western Australia, Pogo mine in Alaska, and Hemi gold project in Western Australia to support a long-term, low-cost growth pathway.The estimates include, for the first time, Northern Star's mineral resources and ore reserves for the Hemi project, which it acquired in May 2025.

ASX:NST

Asia48d ago

Lottery Lowers Fiscal Year 2026 Cost Outlook

Lottery (ASX:TLC) has narrowed its fiscal year 2026 operating expense guidance to AU$300 million to AU$310 million, down from AU$310 million to AU$320 million, while reaffirming capital expenditure of AU$90 to AU$100 million, according to a Wednesday filing with the Australian bourse.

ASX:TLC

International48d ago

New Zealand's Seasonally Adjusted New Dwelling Consents Rise in April

New Zealand's seasonally adjusted new dwellings consents rose 11% to 3,802 in April from 3,429 in the previous month, according to Stats NZ data on Wednesday.In actual terms, 3,692 new dwellings were consented, including 1,604 stand-alone houses, 1,530 townhouses, flats, and units, 499 apartments, and 59 retirement village units.New dwellings consented in the reported month rose nearly 53% in actual terms compared with 2,418 in April 2025.In the 12 months ended April, the actual number of new dwellings consented was up 16% to 39,087 compared with the prior corresponding period."More than half of the annual growth came from multi-unit homes, such as apartments, townhouses, flats, and retirement village units," economic indicators spokesperson Michelle Feyen said.The regions with the highest increase in new home consents in the year ended April were Auckland, up 21%, Waikato, up 6.3%, and Wellington, up 13%.The annual value of non-residential building work consented in April edged down 0.4% year-on-year to NZ$8.9 billion.

^NZ50

Asia48d ago

Superloop Lifts Fiscal 2026 Underlying EBITDA Guidance

Superloop (ASX:SLC) upgraded its fiscal 2026 guidance for underlying earnings before interest, taxes, depreciation, and amortization to AU$118 million to AU$122 million from prior forecast of AU$112 million to AU$120 million, according to a Wednesday Australian bourse filing.The move was driven by strong second-half operating performance and the contribution from the Lightning Broadband acquisition completed in late May, per the filing.Capital expenditure guidance has also been raised by AU$2 million to a range of AU$34 million to AU$37 million, the filing added.

ASX:SLC

Asia48d ago

Ryman Healthcare Mulls Six-Year Fixed-Rate Secured Bond Offer

Ryman Healthcare (ASX:RYM, NZE:RYM) said it is evaluating a proposed issuance of six-year fixed-rate, secured and unsubordinated bonds to institutional and New Zealand retail investors, backed by a guarantee and security package from its guaranteeing group, according to a Wednesday filing with the Australian and New Zealand bourses.Existing holders of the company's RYM010 quoted bonds in custodial accounts may exchange some or all holdings into the new bonds at par on a one-for-one basis, subject to allocation and approval by the company and the relevant bookbuild participant, per the filing.Exchanged bonds will be cancelled, reducing RYM010 supply, and trading is expected to be temporarily suspended during the new bonds' rate-setting and initial quotation period, the filing said.The offer is anticipated to open in the week commencing June 8, subject to a successful bookbuild, the filing added.

ASX:RYMNZE:RYM

Asia48d ago

Cygnus Metals to Be Acquired by Central Asia Metals in AU$232 Million All-Scrip Deal

Cygnus Metals (ASX:CY5) agreed to be acquired by Central Asia Metals in an all-scrip deal that values each Cygnus share at AU$0.176, implying an equity value for the company of around AU$232 million, according to a late Tuesday filing with the Australian bourse.Under a definitive scheme implementation deed, Cygnus shareholders will receive 0.06 new Central Asia Metals share for each Cygnus share held.Existing Central Asia Metals shareholders will own about 70% of the company's enlarged fully diluted issued share capital after the deal, while Cygnus shareholders will own the remaining 30%.The transaction will give Central Asia Metals a flagship development-stage asset through a 100% interest in Canada's Chibougamau copper-gold project.

ASX:CY5

Asia48d ago

Scales Declares Final Dividend for 2025

Scales (NZE:SCL) declared a final dividend of NZ$0.125 per share for full year 2025, payable on July 9 to shareholders of record as of June 25, according to a Wednesday filing with the New Zealand bourse.The company paid a dividend of NZ$0.0775 per share in the prior corresponding period, an earlier filing showed.

NZE:SCL

Asia48d ago

Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration

Telix Pharmaceuticals (ASX:TLX) and United Imaging Healthcare North America entered into a memorandum of understanding (MOU) to evaluate a strategic research partnership in the US focused on developing integrated theranostics technologies that combine diagnostics and targeted therapy, Telix said Tuesday after hours.The partnership will evaluate integrating United Imaging's imaging systems, software, connectivity, and artificial intelligence (AI) tools with the company's molecular imaging portfolio and clinical protocols to enhance theranostic workflows.Key focus areas include improving integration of imaging and radiopharmaceutical workflows, standardizing protocol-driven imaging across sites, enhancing treatment planning and patient monitoring, and developing AI-enabled clinical decision support tools.The initial focus will be on TLX101-Px, a positron emission tomography imaging candidate, with opportunities to expand into additional products and markets, as well as pilot programs and protocol optimization efforts.

ASX:TLX

Showing 24161-24180 of 58653